Alexandre Weinstein Manieu - 30 Dec 2025 Form 4 Insider Report for Pluri Inc. (PLUR)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Jan 2026, 19:43:14 UTC
Prior SEC filing
08 Dec 2025
Next SEC filing
19 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Alexandre Weinstein Manieu

Key filing fact

Alexandre Weinstein Manieu filed Form 4 for Pluri Inc. (PLUR) on 05 Jan 2026.

Key facts

  • This page summarizes Alexandre Weinstein Manieu's Form 4 filing for Pluri Inc. (PLUR).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 05 Jan 2026, 19:43.

Change

  • Previous filing in this sequence was filed on 08 Dec 2025.
  • Current net transaction value: +$2,500,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (2)

CIK 0001833124 Primary reporting owner

Manieu Alexandre Weinstein

Relationship
Director, 10%+ Owner
Address
APT 8002, BURGENSTOCK HOTELS & RESORT,, BURGENSTOCK 30, OBBURGEN, SWITZERLAND
Signature
/s/ Alexandre Weinstein Manieu
Signature date
05 Jan 2026
CIK 0002055515

Chutzpah Holdings Ltd

Relationship
10%+ Owner
Address
4TH FLOOR, LIBERATION HOUSE, CASTLE STREET, ST. HELIER, JERSEY
Signature
/s/ Ana Ventura Authorized Officer For Beaumont (Directors) Limited Sole Corporate Director
Signature date
05 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PLUR transaction

Common Stock

Award

Transaction value
$1,250,000
Shares
+625,000
Change %
Price
$2.00
Shares after
625,000
Date
08 Dec 2025
Ownership
Shares indirectly held through Chutzpah Holdings LP
Footnotes
F1, F2, F3
PLUR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
452,702
Date
30 Dec 2025
Ownership
Shares indirectly held through Plantae Bioscience Ltd.
Footnotes
F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PLUR transaction Derivative

Warrants

Award

Transaction value
$1,250,000
Shares
+625,000
Change %
Price
$2.00
Shares after
625,000
Date
08 Dec 2025
Ownership
Warrants indirectly held through Chutzpah Holdings LP
Underlying class
Common Shares
Underlying amount
625,000
Exercise price
$4.25
Footnotes
F1, F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

On December 8, 2025, Pluri Inc. (the "Company") entered into a Securities Purchase Agreement (the "Securities Purchase Agreement") with Chutzpah Holdings LP, a limited partnership beneficially owned by Mr. Alexandre Weinstein, a non-U.S. investor and an existing shareholder and director of the Company ("Mr. Weinstein"), relating to a private placement offering (the "Offering") of: (i) 625,000 common shares, par value $0.00001 per share (the "Common Shares") of the Company, and (ii) warrants (the "Common Warrants") to purchase up to 625,000 Common Shares. The combined purchase price for each Common Share and Common Warrant is $4.00.

Footnote F2

(Continuation of Footnote 1) The Common Warrants will be exercisable immediately at an exercise price of $4.25 per share and will be exercisable until June 30, 2026. The Common Warrants contain customary anti-dilution provisions and are subject to a 35% beneficial ownership limitation. The Securities Purchase Agreement contains customary representations, warranties and indemnification obligations of the parties.

Footnote F3

This statement is jointly filed by and on behalf of each of Chutzpah Holdings LP ("CHLP"), Chutzpah Holdings Limited ("CHL"), Plantae Bioscience Ltd. ("Plantae") and Mr. Weinstein. Mr. Weinstein indirectly owns 100% of Chutzpah and may be deemed to beneficially own securities owned by Chutzpah. Each reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities.

Footnote F4

Mr. Weinstein indirectly owns approximately 78.32% of PBL and may be deemed to beneficially own securities owned by PBL. Neither the filing of this statement nor anything herein shall be deemed an admission that Mr. Weinstein is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the beneficial owner of any securities owned by PBL. Mr. Weinstein disclaims beneficial ownership of such securities covered by this statement, except to the extent of his pecuniary interest in such securities. Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or13(g) of the Act or any other purpose, a member of a group with respect to the issuer or securities of the issuer.

SEC remarks

Exhibit Index: Exhibit 1 - Joint Filer Information. Exhibit 2 - Joint Filing Agreement dated January 5, 2026. Each reporting person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the beneficial owner of any securities covered by this statement. Each reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities. Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or13(g) of the Act or any other purpose, a member of a group with respect to the issuer or securities of the issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .